FindTrial
Sign In

The usefulness of DPP4 inhibitor among Kidney transplant recipients

The usefulness of DPP4 inhibitor among Kidney transplant recipients: a nationwide cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0006737
Enrollment
10000
Registered
2021-11-10
Start date
2022-03-01
Completion date
Unknown
Last updated
2021-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Yonsei University Wonju College of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: By using specific operation codes and ICD-10 codes, patients extracted from Korean National Health Insurance kidney transplant recipients who received operation between 2002 and 2020.

Exclusion criteria

Exclusion criteria: patients diagnosed diabetes before transplantation

Design outcomes

Primary

MeasureTime frame
survival comparison between DPP4 inhibitor user and Non DPP4 inhibitor user—

Secondary

MeasureTime frame
renal function—

Countries

Korea, Republic of

Contacts

Public ContactJun Young Lee

Yonsei University Wonju College of Medicine

junyoung07@yonsei.ac.kr+82-33-741-0935

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026